Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]

Maseng MJ, Tawe L, Thami PK, et al. Pharmgenomics Pers Med. 2021;14:335–347. The authors have advised that there is an error in Table 6 on page 342. The reference “39” in the third row for the References column should read “41&rd...

Full description

Bibliographic Details
Main Authors: Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
art
cyp2b6 gene
drug resistance selection
fast metabolizers
hiv
Online Access:https://www.dovepress.com/corrigendum-association-of-cyp2b6-genetic-variation-with-efavirenz-and-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/corrigendum-association-of-cyp2b6-genetic-variation-with-efavirenz-and-peer-reviewed-article-PGPM

Similar Items